CA
NZ
UK
AU
IND
US
Angela C. Williams, Vice President and Chief Accounting Officer at CSX Corporation, disclosed a sale of 30,000 common shares on July 24, 2026, at a weighted average price of $53.29 per share. The transaction, filed with the Securities and Exchange Commission on July 27, …
Shane Bohnen, Senior Vice President and General Counsel of Bio-Techne Corp (NASDAQ: TECH), disclosed material changes to his beneficial ownership in the company on July 27, 2026, following transactions executed on July 23, 2026. The filing reveals multiple stock acquisitions and dispositions alongside an …
Roper Technologies Inc. disclosed that John K. Stipancich, Executive Vice President, Chief Legal Officer and Secretary, completed a series of equity transactions on July 27, 2026. Stipancich exercised employee stock options to acquire 2,000 common shares and subsequently sold 2,000 common shares at a …
Roper Technologies Inc., a diversified industrial software and engineered products company trading on NASDAQ under ticker ROP, disclosed that director Richard F. Wallman sold 6,434 shares of common stock on July 24, 2026, at $361 per share. The transaction, reported through a regulatory filing …
Lucas Bruce, Chief Executive Officer, Director, and 10% owner of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), acquired 1 million shares of common stock on July 27, 2026, at $0.0018 per share, according to a regulatory filing. The transaction adds to Bruce's existing beneficial ownership …
Twist Bioscience Corporation disclosed that Patrick John Finn, the company's President and Chief Operating Officer, sold 2,238 shares of common stock on July 23, 2026, at a price of $93.893 per share. The transaction was executed as part of a mandatory tax withholding obligation …
Michael M. Achary, Chief Financial Officer of Hancock Whitney Corp., disclosed the sale of 22,694 shares of common stock on July 24, 2026, at $76.18 per share. The transaction reduced his direct beneficial ownership to 44,159.6404 shares following the disposition. The sale was reported …
Immunome Inc., a NASDAQ-listed biopharmaceutical company, disclosed that Chief Legal Officer and General Counsel Sandra Stoneman acquired equity compensation on July 23, 2026, including 38,250 restricted stock units and 76,500 employee stock options. The transaction, reported in a regulatory filing dated July 27, 2026, …
The Gabelli Multimedia Trust Inc., a closed-end management investment company focused on telecommunications, media, publishing, and entertainment sectors, disclosed an expanded common stock offering of up to 22 million shares through a sales agreement with G.research, LLC. As of July 24, 2026, the Fund …
Immunome Inc. (NASDAQ: IMNM) disclosed that Philip Tsai, the company's Chief Technical Officer, acquired restricted stock units and employee stock options in a transaction dated July 23, 2026. The grant comprised 38,250 restricted stock units and 76,500 stock options exercisable at $22.01 per share. …
Please wait processing your request...